Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.96 |
| ▸ | GAA | P10253 | 2/20 | 0.96 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 5/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.44 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25192670 | 1.00 | KDM4E (0.96) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| Hydrochloric Acid SCHEMBL9566345 | 0.98 | KDM4E (0.93) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| Hydrochloric Acid SCHEMBL4811305 | 0.98 | KDM4E (0.93) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL29100415 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL634215 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL29498815 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL30181949 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| Sulfuric Acid SCHEMBL9566343 | 0.93 | KDM4E (0.83) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL5746726 | 0.88 | ALDH1A1 (0.75) | KDM4EALDH1A1GAAPDPK1KMT2A | |
| SCHEMBL5749892 | 0.88 | ALDH1A1 (0.75) | KDM4EALDH1A1GAAPDPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3003375-B1 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT | HAFEZI FARHAD (CH) | 2019-11-20 | — | — | EP | claimed |
| US-20160120979-A1 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT | HAFEZI FARHAD (CH) | 2016-05-05 | — | — | US | claimed |
| EP-3003375-A2 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT | Hafezi, Farhad (CH) | 2016-04-13 | — | — | EP | claimed |
| US-20150164922-A1 | USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-06-18 | — | — | US | claimed |
| US-20150056160-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. | 2015-02-26 | — | — | US | claimed |
| WO-2014194435-A2 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT | HAFEZI FARHAD (CH) | 2014-12-11 | — | — | WO | claimed |
| US-20140228248-A1 | METHODS AND COMPOSITIONS FOR DETECTING INFECTIONS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2014-08-14 | — | — | US | claimed |
| WO-2013136192-A2 | USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION | FOAMIX LTD. (IL) | 2013-09-19 | — | — | WO | claimed |
| WO-2013048952-A1 | METHODS AND COMPOSITIONS FOR DETECTING INFECTIONS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2013-04-04 | — | — | WO | claimed |
| WO-2008097851-A1 | TETRACYCLINE COMPOSITIONS FOR TOPICAL ADMINISTRATION | WARNER CHILCOTT COMPANY, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| WO-2005085863-A2 | BIOMARKER: COMPOUND CORRELATIONS IN CANCER DIAGNOSIS AND THERAPY | APPLIED GENOMICS, INC. (US) | 2005-09-15 | — | — | WO | claimed |
| EP-1098641-A4 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2003-08-27 | — | — | EP | claimed |
| EP-1098641-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | Texas Pharmaceuticals, Inc. (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000006143-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0536515-A1 | Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1993-04-14 | — | — | EP | claimed |
| EP-0535346-A1 | 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1993-04-07 | — | — | EP | claimed |
| EP-0196376-B1 | ARTICLE COATED WITH AN ANTIFOULING COMPOSITION FOR USE IN SEAWATER | STARBRITE INTERNATIONAL N.V. (AN) | 1989-12-13 | — | — | EP | claimed |
| US-4678512-A | Marine coating compositions and method | GRAMS RALPH R | 1987-07-07 | — | — | US | claimed |
| EP-0196376-A1 | Article coated with an antifouling composition for use in seawater | STARBRITE INTERNATIONAL N.V. (AN) | 1986-10-08 | — | — | EP | claimed |
| US-4552813-A | Method of inhibiting the growth of marine life on surfaces in contact with seawater | GRAMS RALPH R | 1985-11-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160120979-A1 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT | XPA, CD4, TK1 | KDM4E 4556/4885ALDH1A1 2527/4885GAA 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.